Evidence map›Paper›PMID 39659977›Full record

ArticleBrain communications2024

Amygdala-predominant α-synuclein pathology is associated with exacerbated hippocampal neuron loss in Alzheimer's disease.

Klara Gawor, Sandra O Tomé, Rik Vandenberghe, Philip Van Damme, Mathieu Vandenbulcke, Markus Otto, Christine A F von Arnim, Estifanos Ghebremedhin, Alicja Ronisz, Simona Ospitalieri and 2 more

Abstract read
In one paragraph

Article in Brain communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Alpha-synuclein co-pathology in a real-world early Alzheimer's disease cohort.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  6. Where do PDD and DLB SYNdromes fit in neuronal alpha-SYNuclein biological frameworks?Journal of neural transmission (Vienna, Austria : 1996) · 2026
    Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Klara GaworLaboratory for Neuropathology, Department of Imaging and Pathology, KU Leuven, Leuven 3000, Belgium.
Sandra O ToméLaboratory for Neuropathology, Department of Imaging and Pathology, KU Leuven, Leuven 3000, Belgium.ORCID https://orcid.org/0000-0001-5253-0730
Rik VandenbergheLaboratory for Cognitive Neurology, Department of Neurosciences, KU Leuven, Leuven 3000, Belgium.ORCID https://orcid.org/0000-0001-6237-2502
Philip Van DammeDepartment of Neurology, University Hospitals Leuven, Leuven 3000, Belgium.ORCID https://orcid.org/0000-0002-4010-2357
Mathieu VandenbulckeLaboratory for Translational Neuropsychiatry, Department of Neuroscience, KU Leuven, Leuven 3000, Belgium.
Markus OttoDepartment of Neurology, Ulm University, Ulm 89081, Germany.
Christine A F von ArnimDepartment of Neurology, Ulm University, Ulm 89081, Germany.
Estifanos GhebremedhinInstitute for Clinical Neuroanatomy, Johann Wolfgang Goethe University, Frankfurt am Main 60596, Germany.
Alicja RoniszLaboratory for Neuropathology, Department of Imaging and Pathology, KU Leuven, Leuven 3000, Belgium.
Simona OspitalieriLaboratory for Neuropathology, Department of Imaging and Pathology, KU Leuven, Leuven 3000, Belgium.
Matthew BlaschkoProcessing Speech and Images, Department of Electrical Engineering, KU Leuven, Leuven 3000, Belgium.
Dietmar Rudolf ThalLaboratory for Neuropathology, Department of Imaging and Pathology, KU Leuven, Leuven 3000, Belgium.ORCID https://orcid.org/0000-0002-1036-1075

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Misfolded α-synuclein protein accumulates in 43-63% of individuals with symptomatic Alzheimer's disease. Two main patterns of comorbid α-synuclein pathology have been identified: caudo-rostral and amygdala-predominant. α-Synuclein aggregates have been shown to interact with the transactive response DNA-binding protein 43 (TDP-43) and abnormally phosphorylated tau protein. All these proteins accumulate in the amygdala, which is anatomically connected with the hippocampus. However, the specific role of amygdala-predominant α-synuclein pathology in the progression of Alzheimer's disease and hippocampal degeneration remains unclear. In this cross-sectional study, we analysed 291 autopsy brains from both demented and non-demented elderly individuals neuropathologically. Neuronal density in the CA1 region of the hippocampus was assessed for all cases. We semiquantitatively evaluated α-synuclein pathology severity across seven brain regions and calculated a ratio of limbic to brainstem α-synuclein pathology severity, which was used to stratify the cases into two distinct spreading patterns. In the 99 symptomatic Alzheimer's disease cases, we assessed severity of limbic-predominant age-related TDP-43 neuropathological changes and CA1 phosphorylated tau density. We performed triple fluorescence staining of medial temporal lobe samples with antibodies against phosphorylated TDP-43, α-synuclein and phosphorylated tau. Finally, we employed path analysis to determine the association network of various parameters of limbic pathology in Alzheimer's disease cases and CA1 neuronal density. We identified an association between the amygdala-predominant αSyn pathology pattern and decreased neuronal density in the CA1 region. We found that Alzheimer's disease cases with an amygdala-predominant α-synuclein pattern exhibited the highest TDP-43 severity and prevalence of TDP-43 inclusions in the dentate gyrus among all groups, while those with the caudo-rostral pattern had the lowest severity of Alzheimer's disease neuropathological changes. We observed colocalization of TDP-43, aggregated α-synuclein and hyperphosphorylated tau in cytoplasmic inclusions within hippocampal and amygdala neurons of Alzheimer's disease cases. Path analysis modelling suggests that the relationship between amygdala-predominant α-synuclein pathology and CA1 neuron loss is partially mediated by hippocampal tau and TDP-43 aggregates. Our findings suggest that Alzheimer's disease cases with amygdala-predominant α-synuclein pathology may constitute a distinct group with more severe hippocampal damage, a higher TDP-43 burden and potential interactions among α-synuclein, TDP-43 and hyperphosphorylated tau.

Indexed as

dementiaimmunohistochemistryLewy body diseaseneuropathologypath analysis

Identifiers

PMID39659977
PMCPMC11631359

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.